Rate My Professor Mesfin Genie

Dr Mesfin Genie serves as a Continuing Senior Lecturer in Health Economics at the Newcastle Business School, University of Newcastle, Australia. He obtained his PhD in Economics from Ca’ Foscari University of Venice, Italy, where he employed stated preference techniques to understand healthcare decision-making. His earlier qualifications include an MSc in Health Economics and Management from the University of Bologna, Italy, an MSc in Economics from Addis Ababa University, Ethiopia, and a BA in Economics from Jimma University, Ethiopia. Genie has held several research positions at leading institutions, such as Postdoctoral Research Fellow at Auburn University’s Harrison College of Pharmacy from December 2022 to July 2023, Research Fellow at the University of Aberdeen’s Health Economics Research Unit from January 2020 to November 2022, Postdoctoral Research Fellow at Ca’ Foscari University of Venice’s Department of Economics from January 2019 to December 2020, and Health Measurement and Regulatory Science Fellow at Duke University’s Department of Population Health Sciences from July 2023 to January 2024.

His research specializes in behavioural health economics, using discrete choice experiments to study patient preferences in organ transplantation, diabetes, prostate cancer, dementia, loneliness, telemedicine, medical devices, health workforce, and vaccines. Additional foci include information processing in healthcare decisions via eye-tracking technology, improving health measurements to reflect patient values, incorporating equity and efficiency into value-based preference assessments, the role of feedback in heart failure device decisions, moral attitudes in pandemic-related trade-offs, and attribute ordering in multi-attribute choices. At the University of Newcastle, he lectures and coordinates courses in Health Economics and Finance and Behavioural Economics. Key publications comprise “The role of heterogeneity of patients’ preferences in kidney transplantation” (2020, Journal of Health Economics), “To pay or not to pay? Cost information processing in the valuation of publicly funded healthcare” (2021, Social Science & Medicine), “Keeping an eye on cost: What can eye tracking tell us about attention to cost information in discrete choice experiments?” (2023, Health Economics), “Choice Consistency in Discrete Choice Experiments: Does Numeracy Skill Matter?” (2024, Value in Health), “Priority for Self or Others? Incorporating Equity Considerations in a Preference-Based Health Value Assessment” (2025, Value in Health), and “Guidance or Misdirection? Unpacking the Role of Feedback in Health Preference Assessments” (2026, Health Economics). He is Guest Editor for Health Policy and Technology and reviews for journals including Journal of Health Economics and Health Economics.